Posted by: drchasrani on: June 14, 2012
CABG remains the main stay treatment for triple vessel disease. Not only it helps revascularisation but also prevents MI, thus increasing lifespan. Team@CMHF
Posted by: admin on: January 25, 2012
Guidelines of CABG were first issued in 1991 and last revision was in 2004. 2011 witnessed yet another update to the existing guidelines, what with rapidly changing surgical scenario. Team@CMHF
Posted by: admin on: December 27, 2011
Interestingly, number of CABG performed has decreased compared to Angioplasties over past few years. The drop in CABG surgery rates was observed across sex, age, racial and regional subgroups. The reason for this is not one particular factor. Team@CMHF
Posted by: admin on: November 28, 2011
Anti platelet agents are important to prevent CVD. Recent study suggests that low on-clopidogrel platelet reactivity linked to reduced CV event risk. Team@CMHF
Posted by: admin on: November 25, 2011
Selection of the stent is important for the outcome of angioplasty. A study suggests that DES is better choice than BMS, especially in saphenous vein graft lesion patients. Team@CMHF